Literature DB >> 3305939

Levels of metalloproteases and tissue inhibitor of metalloproteases in human osteoarthritic cartilage.

D D Dean, W Azzo, J Martel-Pelletier, J P Pelletier, J F Woessner.   

Abstract

Human articular cartilage contains 2 distinct metalloproteases which degrade proteoglycan. One protease acts optimally at pH 5.3 and the other at pH 7.2. In addition, cartilage contains a tissue inhibitor of metalloproteases (TIMP) that inhibits both proteases. Methods have been developed for the estimation of metalloproteases and TIMP in extracts of cartilage prepared in buffered 2 M guanidine-HCl. In osteoarthritic cartilage, levels of the 2 metalloproteases increase 3-fold or more, while the level of TIMP remains constant. It is postulated that a balance is maintained between inhibitor and metalloprotease levels in normal cartilage and that in osteoarthritis increased secretion of proteases upsets this balance and results in degradation of the extracellular matrix.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3305939

Source DB:  PubMed          Journal:  J Rheumatol        ISSN: 0315-162X            Impact factor:   4.666


  12 in total

1.  Study of the effect of a glycosaminoglycan-peptide complex on the degradative enzyme activities in human osteoarthritic cartilage.

Authors:  E Vignon; A Martin; P Mathieu; T Conrozier; P Louisot; M Richard
Journal:  Clin Rheumatol       Date:  1990-09       Impact factor: 2.980

2.  General protease and collagenase (IV) activity in C6 astrocytoma cells, C6 spheroids and implanted C6 spheroids.

Authors:  I S Vaithilingam; E C Stroude; W McDonald; R F Del Maestro
Journal:  J Neurooncol       Date:  1991-06       Impact factor: 4.130

3.  Gene expression of matrix metalloproteinases 1, 3, and 9 by chondrocytes in osteoarthritic human knee articular cartilage is zone and grade specific.

Authors:  A J Freemont; V Hampson; R Tilman; P Goupille; Y Taiwo; J A Hoyland
Journal:  Ann Rheum Dis       Date:  1997-09       Impact factor: 19.103

4.  Inverse correlation between tyrosine phosphorylation and collagenase production in chondrocytes.

Authors:  T F Cruz; G Mills; K P Pritzker; R A Kandel
Journal:  Biochem J       Date:  1990-08-01       Impact factor: 3.857

5.  In situ zymographic localisation of type II collagen degrading activity in osteoarthritic human articular cartilage.

Authors:  A J Freemont; R J Byers; Y O Taiwo; J A Hoyland
Journal:  Ann Rheum Dis       Date:  1999-06       Impact factor: 19.103

6.  Fibroblast and neutrophil collagenases cleave at two sites in the cartilage aggrecan interglobular domain.

Authors:  A J Fosang; K Last; V Knäuper; P J Neame; G Murphy; T E Hardingham; H Tschesche; J A Hamilton
Journal:  Biochem J       Date:  1993-10-01       Impact factor: 3.857

7.  Differential expression patterns of matrix metalloproteinases and their inhibitors during development of osteoarthritis in a transgenic mouse model.

Authors:  H J Salminen; A-M K Säämänen; M N Vankemmelbeke; P K Auho; M P Perälä; E I Vuorio
Journal:  Ann Rheum Dis       Date:  2002-07       Impact factor: 19.103

8.  Effects of low-level laser therapy on joint pain, synovitis, anabolic, and catabolic factors in a progressive osteoarthritis rabbit model.

Authors:  Pu Wang; Chuan Liu; Xiaotian Yang; Yujing Zhou; Xiaofei Wei; Qiaodan Ji; Lin Yang; Chengqi He
Journal:  Lasers Med Sci       Date:  2014-06-03       Impact factor: 3.161

9.  Evidence for metalloproteinase and metalloproteinase inhibitor imbalance in human osteoarthritic cartilage.

Authors:  D D Dean; J Martel-Pelletier; J P Pelletier; D S Howell; J F Woessner
Journal:  J Clin Invest       Date:  1989-08       Impact factor: 14.808

10.  The Novartis-ILAR Rheumatology Prize 2001 Osteoarthritis: from molecule to man.

Authors:  Jean-Pierre Pelletier; Johanne Martel-Pelletier
Journal:  Arthritis Res       Date:  2001-11-02
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.